Abstract

Background: Changes in population structure, aging pattern, and the increasing prevalence of diabetes and hypertension, are behind the increase in chronic kidney disease (CKD) prevalence and end stage renal disease (ESRD). Reliable and updated information on CKD patients and ESRD patient numbers and treatment modalities are essential to understand the real estimate of the renal disease burden in many countries. It was the aim of our study to investigate different regions of the world, as defined by world health organization (WHO): Africa, the Americas, South East Asia, Europe, East Mediterranean, and West Pacific regions, regarding many aspects of renal disease and renal replacement therapy.

Highlights

  • Chronic Kidney Disease (CKD) is reported with rising prevalence worldwide, and that of End Stage Renal Disease (ESRD)

  • Data will include the prevalence of CKD, the main etiology of CKD, available forms of Renal Replacement Therapy (RRT), Hemodialysis (Hdx), Peritoneal Dialysis (PD) or renal transplantation (Tx), percent of health expenditure and the nephrology workforce in each country

  • Analysis of the collected data were classified according to the studied parameter as follows; percent of health expenditure, prevalence and etiology of CKD, prevalence of RRT, Dx modalities, Tx annual rates and living, deceased donors and nephrology workforce in each of the studied countries

Read more

Summary

Introduction

Chronic Kidney Disease (CKD) is reported with rising prevalence worldwide, and that of End Stage Renal Disease (ESRD). The availability of Renal Replacement Therapy (RRT) including, dialysis and transplantation does not follow the same pattern of increase in many countries, . Reliable and updated information on CKD patients and ESRD patient numbers and treatment modalities are essential to understand the real estimate of the renal disease burden in many countries. It was the aim of our study to investigate different regions of the world, as defined by world health organization (WHO): Africa, the Americas, South East Asia, Europe, East Mediterranean, and West Pacific regions, regarding many aspects of renal disease and renal replacement therapy

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.